Iovance Biotherapeutics
IOVA
#3883
Rank
โ‚น295.80 B
Marketcap
โ‚น639.35
Share price
-5.61%
Change (1 day)
218.58%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2026 (TTM): -โ‚น49.16

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น49.11. In 2025 the company made an earnings per share (EPS) of -โ‚น103.78 an increase over its 2024 EPS that were of -โ‚น120.46.

EPS history for Iovance Biotherapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น49.16-52.63%
2025-โ‚น103.78-13.85%
2024-โ‚น120.46
2022-โ‚น229.8011.71%
2021-โ‚น205.71
2019-โ‚น146.4023.44%
2018-โ‚น118.60-9.22%
2017-โ‚น130.65-20.34%
2016-โ‚น164.01176.56%
2015-โ‚น59.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น5.56-88.68% Bahamas
NRC Health
NRC
โ‚น26.87-154.72%๐Ÿ‡บ๐Ÿ‡ธ USA